COVID-19: New adaptation for IVF laboratory protocols.
JBRA Assist Reprod
; 24(3): 358-361, 2020 07 14.
Article
in English
| MEDLINE | ID: covidwho-618561
ABSTRACT
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) widely known as COVID-19 was first reported in late December 2019, in China. Since then this novel coronavirus has spread throughout the world. Our return to normal life will not take long, for we are in a phase where the COVID-19 curve is stabilizing. ART services must return to operation, since infertility is also a disease and treatment has to start. Before resuming ART treatments, it is very important to consider local and national regulations. Change is mandatory, to set us back to successful ART treatment without compromising on quality, and to minimize the spread of COVID-19 among staff and patients; and for this we need to take measured and vigilant steps.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Fertilization in Vitro
/
Coronavirus Infections
/
Pandemics
Limits:
Humans
Language:
English
Journal:
JBRA Assist Reprod
Year:
2020
Document Type:
Article
Affiliation country:
1518-0557.20200054
Similar
MEDLINE
...
LILACS
LIS